The purpose of this study is to determine the PK, safety and tolerability of multiple doses of intravenous (i.v.) secukinumab in pediatric participants with JPsA
- Investigator
- Melissa E Elder
- Ages
- 2 Years - 17 Years
- Sexes
- All
Clinical trials
-
CAIN457G22101